Below are the most recent publications written about "Positron-Emission Tomography" by people in Profiles.
-
H?ilund-Carlsen PF, Alavi A, Costa T, Neve RL, Perry G, Revheim ME, Barrio JR. Is US residence a risk factor for Alzheimer's disease? J Alzheimers Dis. 2025 Sep; 107(2):496-498.
-
Windon CC, Gatsonis C, Carrillo MC, Romanoff J, Hanna L, Glavin E, Gareen I, Gutman R, Hillner BE, March A, O'Bryant S, Rissman RA, Siegel BA, Smith K, Whitmer RA, Weber CJ, Wilkins CH, Dilworth-Anderson P, Rabinovici GD. Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study. Alzheimers Dement. 2025 Jul; 21(7):e70504.
-
Liang J, Hussainy S, Lee SM, Wu G, Bautista N, Ding M, Wang H, LaFleur B, Perry G, Wang X. Association of Polygenic Risk Score for 5 Diseases With Alzheimer Disease Progression, Biomarkers, and Amyloid Deposition. Neurology. 2025 Feb 25; 104(4):e210250.
-
Lowe VJ, Mester CT, Lundt ES, Lee J, Ghatamaneni S, Algeciras-Schimnich A, Campbell MR, Graff-Radford J, Nguyen A, Min HK, Senjem ML, Machulda MM, Schwarz CG, Dickson DW, Murray ME, Kandimalla KK, Kantarci K, Boeve B, Vemuri P, Jones DT, Knopman D, Jack CR, Petersen RC, Mielke MM. Amyloid PET detects the deposition of brain A? earlier than CSF fluid biomarkers. Alzheimers Dement. 2024 Nov; 20(11):8097-8112.
-
Baldelomar EJ, Zhang H, Thorek D, Charlton JR, Walker PD, Wilson LD, Emoto KC, Clavijo Jordan V, Reichert DE, Shoghi K, Bennett KM. Development and Use of Human Recombinant 64Cu-rHCF as a Kidney Glomerulus-Targeted Contrast Agent for Positron Emission Tomography. ACS Appl Bio Mater. 2024 10 21; 7(10):6392-6397.
-
Chan AM, Olafsen T, Tsui J, Salazar FB, Aguirre B, Zettlitz KA, Condro M, Wu AM, Braun J, Gordon LK, Ashki N, Whitelegge J, Xu S, Ikotun O, Lee JT, Wadehra M. 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Mol Cancer Ther. 2024 Jun 04; 23(6):890-903.
-
Smith HS, Robinson JO, Levchenko A, Pereira S, Pascual B, Bradbury K, Arbones V, Fong J, Shulman JM, McGuire AL, Masdeu J. Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease. J Alzheimers Dis. 2024; 97(3):1261-1274.
-
H?ilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B. Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village. Ageing Res Rev. 2024 01; 93:102173.
-
Sood A, Kishan AU, Evans CP, Feng FY, Morgan TM, Murphy DG, Padhani AR, Pinto P, Van der Poel HG, Tilki D, Briganti A, Abdollah F. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature. Eur Urol Oncol. 2024 Feb; 7(1):27-43.
-
Andrews JR, Sood A, Chapin BF. Point-Counterpoint: Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Detecting Clinically Node Positive Prostate Cancer. J Urol. 2023 08; 210(2):242-243.